26/06/2016

Proyectos y Publicaciones

Artículos de revistas

  • Characterization of Yeasts and Filamentous Fungi using MALDI Lipid Phenotyping | G. Stübiger, M.D. Nairn, T.K. Abban, M.E. Openshaw, L. Mancera, B. Herzig, M. Wuczkowski, D. Senfter, R.M. Mader | Journal of Microbiological Methods. Vol 130, pp. 27-37. November 2016 (+ info).
  • MALDI-MS Protein Profiling of Chemoresistance in Extracellular Vesicles of Cancer Cells | G. Stübiger, M.D. Nairn, T.K. Abban, M.E. Openshaw, L. Mancera, B. Herzig, M. Wuczkowski, D. Senfter, R.M. Mader | Analytical Chemistry. November 2018 (+ info).
  • Discrimination among Cryptococcus neoformans var. neoformans, C. neoformans var. grubii and interspecies hybrids using MALDI-TOF Mass Spectrometry | E. Zvezdanova, M. Arroyo, G. Méndez, J.V. Guinea Ortega, L. Mancera, P. Muñoz, B. Rodríguez-Sánchez, P. Escribano | Clinical Microbiology and Infection. Submitted.

Conferencias internacionales

  • MALDI-nanochip based Screening of Exosomal Biomarkers: Application to Cancer Diagnostics, American Society for Mass Spectrometry (ASMS 2020); Michael D. Nairn1; Michael Wuczkowsky2; Jesús Jiménez3; Iris Prinz4; Marco Rissoglio5; Gerald Stubiger61. Shimadzu, Manchester, UK;2Medical University of Vienna, Vienna, Austria3Clover Bioanalytical Software, Granada, Spain; 4Stratec Consumables,, Salzburg, Austria; 5Tethis, Milan, Italy; 6Comprehensive Cancer Center, Vienna, Austria
  • Rapid MALDI-TOF MS-based method for vancomycin-resistant Enterococcus faecium detection | 30th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2020) | Ana Candela1, Lidia Quiroga1, Manuel J. Arroyo2, Adrián Ruiz1, Emilia Cercenado1, Gema Méndez2, Mercedes Marín1, Patricia Muñoz1, Luis Mancera2, Belén Rodríguez-Sánchez1 | 1Hospital General Universitario Gregorio Marañón, Madrid, Spain. 2Clover Bioanalytical Software, Granada, Spain
  • Accurate differentiation of carbapenemases by MALDI-TOF MS-typing: employment of bioinformatics | 30th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2020) | Eva Gato1, Bruno Kotska Rodiño1, Gema Méndez2, Manuel J. Arroyo2, Luis Mancera2, Germán Bou1, Marina Oviaño1 | 1Clinical Microbiology and Infectious Diseases Department, Hospital Universitario A Coruña, Spain. 2Clover Bioanalytical Software, Spain
  • Evaluation of a novel method for detection of carbapenem hydrolysis with an automated software (Clover BioSoft) by MALDI-TOF MS, 30th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2020); Eva Gato1, Gema Méndez2, Luis Mancera2, Germán Bou1, Marina Oviaño11Clinical Microbiology and Infectious Diseases Department, Hospital Universitario A Coruña, Spain. 2Clover Bioanalytical Software, Spain
  • Detection of Vancomycin-Resistant Enterococcus faecium Using MALDI-TOF Mass Spectrometry, Annual Congress in Clinical Mass Spectrometry (MSACL 2019); Manuel Arroyo1, Adrián Ruiz2, Luis Mancera1, Lidia Quiroga2, Emilia Cercenado2, Belén Rodríguez Sánchez21Clover Bioanalytical Software, Spain2Hospital General Universitario Gregorio Marañón, Spain.
  • Use of MALDI-TOF Mass Spectrometry and Machine Learning to Detect the Adulteration of Extra Virgin Olive oils, American Society for Mass Spectrometry (ASMS 2018); Simona Salivo1; Tom K. Abban1; Ismael Duque2; Luis Mancera2; Matthew E. Openshaw1; 1Shimadzu, Manchester, UK;2Clover Bioanalytical Software, Granada, Spain (+ info).
  • A Novel Software for the Characterization of Microorganisms Using Lipid Phenotyping and Statistical Analysis of MALDI-MS Data, American Society for Mass Spectrometry (ASMS 2018); Gema Méndez-Cervantes1; Luis Mancera1; Gerald Stübiger2; 1Clover Bioanalytical Software, Granada, Spain; 2Medical University of Vienna, Vienna, Austria (+ info).
  • Metrological characterization of the reproducibility of MALDI-TOF MS for bacterial strain typing, 28th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2018); Eloise Busby, Jim Hugget, Tim McHugh, Emmanuel Wey; University College London, UK (+info)
  • Evaluation of critical parameters for the establishment of a clinical MALDI applications platform for liquid biopsy diagnostics, Accelerating Clinical Mass Spectrometry Europe (MSACL EU 2017); Gerald Stubiger1; Emanuele Barborini1; Iris Prinz Werner1; Luis Mancera2; Michael Wuckzkowski1; ; 1Medical University of Vienna, Austria; 2Clover Bioanalytical Software, Granada, Spain.
  • Blind Source Separation of MALDI Spectra from Noise by Sparse Representation in a Composite of Linear Bases, American Society for Mass Spectrometry (ASMS 2017); Luis Mancera1; Luis González-Jaime1; Matthew Openshaw2; 1Clover Bioanalytical Software, Granada, Spain;  2Shimadzu, Kratos Manchester, United Kingdom (+ info).
  • Dimensionality reduction of MALDI Imaging datasets using non-linear redundant wavelet transform-based representations, American Society for Mass Spectrometry (ASMS 2016); Luis Mancera1; Lyna Sellami2; Jamie Cunliffe2; Luis González-Jaime1; Omar Belgacem2; 1Clover Bioanalytical Software, Granada, Spain; 2Shimadzu, Kratos Manchester, United Kingdom (+ info).
  • MALDI mass spectrometry imaging in Alzheimer’s disease mouse model Het CRND8 (+/-), American Society for Mass Spectrometry (ASMS 2016);
    Lyna Sellami1; Marcia Roy2; Matthew E Openshaw11; Luis Mancera3; Omar Belgacem1; 1Shimadzu, Kratos Manchester, United Kingdom; 2University of Edinburgh, Edinburgh, UK; 3Clover Bioanalytical Software, Granada, Spain.
  • Development of a novel MALDI-MS based liquid biopsy detection platform, CBMED Biomarker Research (CBMED 2016);
    Gerald Stubiger1, 2; Luis Mancera3; Omar Belgacem4; ; 1Medical University of Vienna, Austria;  2 CBmed GmbH – Center for Biomarker Research for Medicine, Graz, Austria; 3Clover Bioanalytical Software, Granada, Spain; Shimadzu, Manchester, United Kingdom (+ info).
es_ESES
en_GBEN es_ESES